JSR Life Sciences LLC, a group company under JSR Corp. (TYO:4185), recently announced that it will be expanding cutting-edge facilities in Europe to grow its business for biopharmaceuticals. These facilities will serve to bolster the activities of two affiliates: namely, U.S.-based KBI Biopharma Inc. and Swiss-based Selexis SA. Through this expansion, the two affiliates will end up occupying a combined…
